Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes - Wikidata - wikimedia - TriplyDB

Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes

Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes

http://www.wikidata.org/entity/Q37175702

about

The evolution of traumatic brain injury in a rat focal contusion model Cell-based therapy for traumatic brain injury Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head Far-red tracer analysis of traumatic cerebrovascular permeability.Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.Molecular and cellular immune responses to ischemic brain injury Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B.Pro-inflammatory interferon gamma signaling is directly associated with stroke induced neurodegeneration.Targeting the peripheral inflammatory response to stroke: role of the spleen Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.Intravenous transplantation of very small embryonic like stem cells in treatment of diabetes mellitus.Failure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat.Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke.Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.Update on stem cell therapy for cerebral palsy Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1.Human cord blood for the hypoxic-ischemic neonate Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.Functional assessment of long-term deficits in rodent models of traumatic brain injury.Stem cells for brain repair in neonatal hypoxia-ischemia.Progenitor cells: therapeutic targets after traumatic brain injury.Radiopharmaceutical stem cell tracking for neurological diseases.The role of the spleen in ischemic stroke.Concise Review: Cell Therapies for Stroke and Traumatic Brain Injury: Targeting Microglia.Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain.Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis.Efficiency of systemic versus intralesional bone marrow-derived stem cells in regeneration of oral mucosa after induction of formocresol induced ulcers in dogs.Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.

P2860

Q24289524-BC563927-D643-4552-812B-96A297113B5D Q26998959-B2C4D17C-9F49-4A94-9013-6F4814351701 Q27305817-96C27FCD-3C53-4C38-B56E-026BFB1A4A4C Q27322703-820EDF6D-25B6-4C72-85DA-8456F6DC6599 Q33793184-58B32D05-A8D4-4154-A374-201944B704A3 Q33895903-641264F5-554E-470C-82AE-AAD80B216497 Q33981407-5AF616C9-E773-4235-8FF3-E32FD45A04B4 Q34016804-8149A45F-2BBB-4745-BA37-F6D489470622 Q34042955-D95EEB82-0D6D-4403-B05D-5AB838988FA3 Q34306920-D4026D4A-BCB2-4802-BBE6-6D1E3E91025F Q34403060-AEF14D74-7989-44EB-98DA-327DBB38B012 Q34429117-65A7818C-4984-47EF-9CC8-3F2C05E991FC Q34591087-CB25BD29-78BC-466C-B81B-585F2C0CF798 Q35151981-FA63B58B-D5BC-45DC-BE1A-B68CDFC7DFF2 Q35307069-069E85E7-2E05-448F-993F-0AA1C3611805 Q35577615-49AB0179-7DA4-4D07-8579-E830CB6F5B90 Q35974305-A0F62DE6-2223-4716-A29A-2621420AB4D5 Q36070752-79C7929B-7ED6-4C86-87AF-3DDB4348D203 Q36539131-3207581E-8EC6-48EB-AC1B-006A2D47447E Q36852274-17DE1FCA-48AB-4BD4-9565-FFABFFD2589B Q36932960-00EB4DAD-48FF-4A68-9350-998D6F6C3D19 Q37399945-73FA46EC-80F0-46A2-B8C1-FD07C9C33599 Q37589712-FBDDEBF2-C789-473A-9F97-087C4DE26AF4 Q37836913-6D98DB86-1C0C-4306-B7AB-30A5298B37BB Q37950344-DB2F4688-1695-4C29-A0D6-59245433B193 Q37978776-8FB53312-208A-45C5-96E0-BF69191ACF50 Q38064454-A7AA6FDC-ACE2-48E8-8AE3-A86BA19C9473 Q38119246-2C342704-EE77-42BC-AEBD-51012EB9B7D6 Q38157667-B8D5F4B4-ECEE-430A-A74D-DF54394A6161 Q38170059-82B5324D-B440-45EB-9207-7E7FD24343F4 Q38225145-F5271299-CC97-43F1-9BE2-D6EBC5551182 Q38281288-F2917E84-71BB-439C-AAD7-B9EC2A35FBE5 Q38722542-CB4FA283-DE3C-4F71-A63C-1236F793201F Q38733373-3DF40F2C-4D5E-42C4-81A1-DBE8F51E8306 Q38916628-97A4BCC7-FF84-4A44-BAFA-E6C334659E73 Q38928462-87E13752-DCBD-4282-B0BA-62E0C572D611 Q39020468-62BD0463-AF86-4C6D-99FE-A48925EE03F3 Q39175537-5B36A704-D635-40C2-940A-B5B9689B97A1 Q39228433-451ABEDB-327E-462E-9AF9-8D33522DF652 Q39414868-F6057374-81C0-48E9-92CF-3548B2F0BA5B

P2860

Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes

http://www.wikidata.org/entity/Q37175702

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intravenous multipotent adult ...... n interaction with splenocytes

@en

Intravenous multipotent adult ...... interaction with splenocytes.

@nl

type

label

Intravenous multipotent adult ...... n interaction with splenocytes

@en

Intravenous multipotent adult ...... interaction with splenocytes.

@nl

prefLabel

Intravenous multipotent adult ...... n interaction with splenocytes

@en

Intravenous multipotent adult ...... interaction with splenocytes.

@nl

P1433

Q37175702-B665B9C8-33A0-4828-BC75-8EAB808F246C

P1476

Q37175702-B365D94F-1379-4341-8E3C-28543410D5AF

P2093

Q37175702-17911D93-8A5B-40EF-AE50-2474C6011EAB

Q37175702-2E0755F6-2ACD-43BF-9917-5A9DD086CDE6

Q37175702-382203C7-1CAC-4B45-A1A5-6552296E9F48

Q37175702-3DCE24EF-B7F9-4DB9-9395-81B8536532EA

Q37175702-424D2611-1226-4F4A-B3B5-0BA60993B2BC

Q37175702-48CAC129-6FE4-4128-9A41-1E299C1052D0

Q37175702-5838797E-0682-4C84-BBEF-683F43F18FFD

Q37175702-611A07F3-5661-4838-8886-5455E4426656

Q37175702-A08F82A3-2C28-4CBF-9696-1D410510118B

Q37175702-BAA59E6B-946E-4B92-B7DE-2BE490B7C98D

P2860

Q37175702-0490289D-4307-4F39-8B1B-B210DCC88ED0

Q37175702-0BE0A1A2-E8A7-437D-96F6-885EF06F3A4A

Q37175702-1577772F-055A-4FEE-94B2-AB44143BA2B0

Q37175702-158898BF-02D6-45C9-8188-E2724AA4E594

Q37175702-2720FEBE-613F-464D-A15B-20FB7F0CBA67

Q37175702-3EB55C43-B21C-40AF-95E6-868F16D65DBD

Q37175702-4EF54C60-0B4D-48DE-A30A-6009CAE0DC04

Q37175702-61B3A5A5-4E8D-48E0-A4CF-462CB4F27B50

Q37175702-8916867C-8466-4982-90F6-42841504E6B7

Q37175702-9595B592-3D6F-47FB-B877-D76F6FB90155

P304

Q37175702-5BB44549-D5AA-4A46-A3FB-97C7D81ECC43

P31

Q37175702-F0E7B80B-8CDE-454C-A8B8-78EC4C91B22B

P356

Q37175702-19E899E4-FD91-4E95-8560-D6DD3DCE6676

P407

Q37175702-37A0F80E-B1E5-4634-BEE5-80F27D4CF480

P433

Q37175702-C58B5C21-E8D9-4FA6-9E1F-3EB7A3679B9B

P478

Q37175702-12BB7E9D-C3A1-419D-8AD6-9E4CA7B09385

P577

Q37175702-68118B33-B23A-4253-AC56-DC31A785D4A3

P5875

Q37175702-A9F89F68-3D70-43D5-AFC9-C13A4C61AA07

P698

Q37175702-E01AAE86-E6CE-4FC8-BBE9-107144D5B676

P921

Q37175702-61F3E890-D0EF-4491-8AA0-81EFBB0A7781

Q37175702-E897A66E-198C-4DE8-955E-03341C317654

P932

Q37175702-53E88C16-4B75-4AAC-8B44-FE65EF904C31

P356

J.EXPNEUROL.2010.07.005

P1433

Experimental Neurology

P1476

Intravenous multipotent adult ...... n interaction with splenocytes

@en

P2093

Charles S Cox

http://www.w3.org/2001/XMLSchema#string

Fernando Jimenez

http://www.w3.org/2001/XMLSchema#string

Hasen Xue

http://www.w3.org/2001/XMLSchema#string

Jason A Hamilton

http://www.w3.org/2001/XMLSchema#string

Michael H Gerber

http://www.w3.org/2001/XMLSchema#string

Peter A Walker

http://www.w3.org/2001/XMLSchema#string

Pramod K Dash

http://www.w3.org/2001/XMLSchema#string

Robert Deans

http://www.w3.org/2001/XMLSchema#string

Robert W Mays

http://www.w3.org/2001/XMLSchema#string

Rochelle Cutrone

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs

Intravenous mesenchymal stem cell therapy for traumatic brain injury

Cord blood rescues stroke-induced changes in splenocyte phenotype and function.

Elusive mechanisms of "stem cell"-mediated repair of cerebral damage.

Beta-blocker exposure is associated with improved survival after severe traumatic brain injury.

Treatment of traumatic brain injury in mice with marrow stromal cells.

Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation

Using a cost-benefit analysis to estimate outcomes of a clinical treatment guideline: testing theBrain Trauma Foundation guidelines for the treatment of severe traumatic brain injury.

Blockade of adrenoreceptors inhibits the splenic response to stroke.

P304

341-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2010.07.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

225

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45270200

http://www.w3.org/2001/XMLSchema#string

P698

20637752

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

blood–brain barrier

P932

3774549

http://www.w3.org/2001/XMLSchema#string